Correct Timing of Head Imaging in Trauma
CT-HIT
1 other identifier
observational
3,200
1 country
1
Brief Summary
The aims of this retrospective and monocentric observational study are: to describe patient characteristics and clinical management of patients with traumatic brain injury taking antiplatelet and/or anticoagulation drugs; to estimate the proportion of patients who suffer an adverse outcome; to assess the risk for serious events (intracranial haemorrhage, in-hospital mortality, need for surgery); to identify potential predictors of outcome and assess potential differences between anticoagulation and antiplatelet therapy. All patients with mild brain injury and anticoagulant or antiplatelet therapy who underwent a head computed tomography (CT) scan admitted to the emergency department (ED) of the University Hospital of Padova, Italy, from 01/01/2010 to 31/12/2020.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 23, 2022
CompletedFirst Posted
Study publicly available on registry
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedJune 1, 2022
May 1, 2022
10 months
March 23, 2022
May 27, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Diagnosis of intracranial hemorrhage
Diagnosis of intracranial hemorrhage
30 days
Secondary Outcomes (2)
Need for surgery at 30-days-follow-up
30 days
Mortality for traumatic brain injury at 30-days-follow up
30 days
Interventions
Eligibility Criteria
Patients with mild brain injury and anticoagulant or antiplatelet therapy who underwent a head CT scan and have been admitted to the Emergency Department
You may qualify if:
- A head computed tomography (CT) scan following head trauma
- Age ≥18 Years
- Anticoagulant and/or antiplatelet therapy
You may not qualify if:
- moderate or severe brain injury (GCS ≤ 13 in the initial assessment in the ED)
- concomitant severe thoracic trauma with hypoxia (satO2 \< 90% room air)
- active bleeding and/or hemodynamic instability
- intracranial haemorrhage with features suggesting spontaneous bleeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Padovalead
- University Hospital Padovacollaborator
Study Sites (1)
Azienda Ospedale Università Padova
Padua, PD, 35128, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 23, 2022
First Posted
April 1, 2022
Study Start
March 1, 2022
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
June 1, 2022
Record last verified: 2022-05